Self-monitoring blood pressure in pregnancy: is this the way forward?

Br J Cardiol 2017;24:87–8doi:10.5837/bjc.2017.021 Leave a comment
Click any image to enlarge

Hypertension is a significant problem, both in the general population and among pregnant women, with around one in 10 women experiencing a form of hypertensive disorder during pregnancy.1 It is the third most common direct cause of maternal mortality worldwide, after haemorrhage and infection,2 and is also associated with adverse affects to the baby, including intrauterine growth retardation, premature delivery and respiratory distress syndrome.3

Current guidelines state that blood pressure should be monitored routinely at antenatal appointments, with increased frequency in high-risk pregnancy and if problems develop.4 Self-monitoring enables women to monitor their own blood pressure between routine appointments, potentially identifying hypertension earlier and aiding management once it is established.5

Self-monitoring is becoming increasingly popular among patients and healthcare professionals. One US study found that 60% of women with hypertension in pregnancy were self-monitoring.6 However, few studies have assessed its safety and effectiveness and whether it will have any effect on the outcomes of pregnancy.5

Accuracy of self-monitoring

Clear thresholds for self-monitoring of hypertension during pregnancy have yet to be established,7 making assessing its utility tricky. Blood pressure fluctuates through the trimesters; with a small drop in blood pressure over the first two trimesters and a subsequent return to non-pregnant levels in the third trimester. As with hypertension in the general population, 140/90 mmHg is the accepted threshold for the diagnosis of hypertension across all trimesters.8

Walshaw Self monitoring

Despite there already being a large number of home monitors available for self-monitoring, only five have been validated and deemed accurate for use during pregnancy.5 Interestingly, some monitors validated in a general population are inaccurate in pregnant women, mostly due to clinically significant false low readings.9 The cause of this is thought to be due to reduced arterial compliance, increased systemic vascular resistance, and increased intravascular volume, which can lead to an incorrect reading at a given pressure in the cuff.10 Peripheral oedema is also present in 80% of normal pregnancies, with the majority of this occurring during the second trimester.11 This may cause blood pressure monitors to underestimate diastolic pressure by a clinically significant average of 9 mmHg.12 Obesity can also affect the ability of otherwise accurate monitors to operate in pregnancy.13 Despite this, a recent Australian study showed that many devices used opportunistically by women are accurate in pregnancy, but that up to a quarter of them will have a blood pressure difference of at least 5 mmHg compared against an accurate reference standard.14

Self-monitoring outside of pregnancy has been reported to be associated with selective reporting of blood pressure.15 However, given an accurate monitor, it appears women are able to self-monitor and report back accurately: an observational study showed that only 2.9% of home blood pressure readings were inaccurate (compared to monitor memories) among women who were at high risk of pre-eclampsia.16 These results indicate that self-monitoring is entirely feasible among high-risk groups.

Effects on pregnancy outcomes

One of the main advantages of self-monitoring is the potential for more frequent monitoring, hence, the hope that this will allow earlier detection of hypertensive disorders, such as pre-eclampsia. A study showed that 81% of women who were self-monitoring did at least six blood pressure measurements a day, and all women involved did at least two measurements per week.17 There is also potential for self-monitoring to free the time of healthcare professionals, as it could reduce the need for additional antenatal appointments simply to measure blood pressure. Another potential benefit is increased treatment compliance: outside of pregnancy, studies have shown a small but significant effect on medication adherence.18

It is not yet known whether self-monitoring will alter pregnancy outcomes due to a lack of available evidence. A pilot randomised-controlled trial compared a control group receiving nine antenatal visits to an experimental group with a reduced number of appointments but who were also self-monitoring. There was an increase in unscheduled visits in the experimental group, however, there were fewer visits overall and an increase in the overall number of blood pressure measurements taken. The majority of the women in the study stated they preferred self-monitoring and there was no significant difference in levels of anxiety experienced between the two groups.19 This shows that self-monitoring is seen as acceptable to pregnant women. A larger trial would be required to indicate whether there would be an effect on the outcomes of pregnancy, but this pilot study indicates that a larger trial should be feasible and safe.

Several new studies are currently underway, one of which is looking at whether self-monitoring of blood pressure can lead to an earlier diagnosis of raised blood pressure in pregnancy.20 Evidence from studies, such as this, should give an indication as to whether self-monitoring could be beneficial for diagnosis and management of hypertension during pregnancy.

Medicalisation of healthcare

Pregnancy and childbirth have been described as becoming increasingly medicalised since the early 20th century, and to some, self-monitoring may be seen as further medicalisation.21 The responsibility of frequent self-monitoring of blood pressure could be too much for some patients, and this could induce problems, such as anxiety, as they may find it too much pressure or commitment, especially if they have to take multiple readings per day. In addition to this, some patients may get obsessive over their blood pressure readings and check them more often than required or may overreact about small changes in their readings. This could in turn lead to increased blood pressure due to anxiety.

On the other hand, to a patient who may not have a great deal of medical knowledge, they might not understand the purpose and importance of monitoring blood pressure. Self-monitoring could help to break down barriers between the doctor and patient as it would allow for greater patient involvement in their healthcare, and the patient may feel more in control. A post-partum questionnaire showed that 98% of women with hypertension liked being involved in their blood pressure management.6 Therefore, self-monitoring could simultaneously be seen to decrease the medicalisation of pregnancy.

What happens next?

As mentioned previously, self-monitoring is becoming increasingly popular and research has suggested that pregnant women prefer this method of monitoring over clinic and ambulatory measurements.

However, there is currently a lack of evidence to suggest whether self-monitoring during pregnancy is the best way forward and whether it will have any impact on the outcomes of pregnancy. In order to establish self-monitoring as safe and effective during pregnancy, further research is needed to ensure it is the best option for both mother and baby.

Conflict of interest

JW: none declared. RJM has received blood pressure monitors for research purposes from Lloyds Pharmacy and Omron.


1. Mustafa R, Ahmed S, Gupta A, Venuto RC. A comprehensive review of hypertension in pregnancy. J Pregnancy 2012;2012:105918.

2. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066–74.

3. Altman D, Carroli G, Duley L et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial: a randomised placebo-controlled trial. Lancet 2002;359:1877–90.

4. National Institute for Health and Care Excellence. Antenatal care for uncomplicated pregnancies. Clinical guideline 62. London: NICE, 2008. Available from:

5. Hodgkinson JA, Tucker KL, Crawford C et al. Is self monitoring of blood pressure in pregnancy safe and effective? BMJ 2014;349:g6616.

6. Magee LA, von Dadelszen P, Chan S et al. Women’s views of their experiences in the CHIPS (Control of Hypertension in Pregnancy Study) pilot trial. Hypertens Pregnancy 2007;26:371–87.

7. National Heart, Lung, and Blood Institute. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, MD: NHLBI, August 2004. Available from:

8. National Institute for Health and Care Excellence. Hypertension in pregnancy: diagnosis and management. Clinical guideline 107. London: NICE, 2010. Available from:

9. Schwartz WJ 3rd, Rayburn WF, Turnbull Gl, Christensen HD. Blood pressure monitoring during pregnancy. Accuracy of portable devices designed for obese patients. J Reprod Med 1996;41:581–5.

10. Reinders A, Cuckson AC, Jones CR, Poet R, O’Sullivan G, Shennan AH. Validation of the Welch Allyn ‘Vital Signs’ blood pressure measurement device in pregnancy and pre-eclampsia. BJOG 2003;110:134–8.

11. Cho S, Atwood JE. Peripheral edema. Am J Med 2002;113:580–6.

12. Ghaffari S, Malaki M, Rezaeifar A, Abdollahi Fakhim S. Effect of peripheral edema on oscillometric blood pressure measurement. J Cardiovasc Thorac Res 2014;6:217–21.

13. James L, Nzelu D, Hay A, Shennan A, Kametas NA. Validation of the Omron MIT Elite blood pressure device in a pregnant population with large arm circumference. Blood Press Monit 2017;22:109–11.

14. Tremonti C, Beddoe J, Brown MA. Reliability of home blood pressure monitoring devices in pregnancy. Pregnancy Hypertens 2017;8:9–14.

15. Wagner S, Toftegaard TS, Bertelsen OW. Challenges in blood pressure self-measurement. Int J Telemed Appl 2012;2012:437350.

16. Waugh J, Habiba MA, Bosio P, Boyce T, Shennan A, Halligan AWF. Patient initiated home blood pressure recordings are accurate in hypertensive pregnant women. Hypertens Pregnancy 2003;22:93–7.

17. Chung Y, de Greeff A, Shennan A. Validation and compliance of a home monitoring device in pregnancy: microlife WatchBP home. Hypertens Pregnancy 2009;28:348–59.

18. Fletcher BR, Hartmann-Boyce J, Hinton L, McManus RJ. The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. Am J Hypertens 2015;28:1209–21.

19. Ross-McGill H, Hewison J, Hirst J et al. Antenatal home blood pressure monitoring: a pilot randomised controlled trial. BJOG 2000;107:217–21.

20. Nuffield Department of Primary Care Health Sciences. Self-monitoring and self-managing blood pressure for earlier pre-eclampsia diagnosis. Oxford: University of Oxford, 2016. Available from:

21. Johanson R, Newburn M, Macfarlane A. Has the medicalisation of childbirth gone too far? BMJ 2002;324:892–5.